LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial
Titel:
LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial
Auteur:
Bruix, J. Merle, P. Granito, A. Huang, Y.-H. Bodoky, G. Yokosuka, O. Rosmorduc, O. Breder, V. Gerolami, R. Masi, G. Ross Paul, J. Qin, S. Song, T. Bronowicki, J.-P. Ollivier-Hourmand, I. Kudo, M. LeBerre, M.-A. Baumhauer, A. Meinhardt, G. Han, G.